Search
Keros Therapeutics Inc
KROSAdd to Watchlist
10.070USD
-0.150-1.47%
Close 07-31 16:00（ET）Quotes delayed by 15 min
199.30MMarket Cap
LossP/E TTM
Keros Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Keros Therapeutics Inc is 7.22, ranking 196 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.98, which is -1228.40% below the recent high of 44.91 and -2688.59% above the recent low of -110.99.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.